Introduction
============

The most critical period of the human being is during fetal development, the stage in which the mother could expose the fetus to adverse environment that could have a long-term effect during adulthood. The studies of Barker and colleagues are the fundament for what is known as developmental programming of diseases, in which they found an inverse relationship between birth weight and cardiovascular diseases later in the adulthood [@B1], [@B2]. Two of the most common challenges to the fetus during development are reduction in oxygen and nutrient delivery. There are various maternal stressors that could affect body weight in the offspring, for example maternal protein-restriction diet [@B3], nicotine exposure [@B4], intrauterine malnutrition [@B5], and hypoxia [@B6].

Retardation of renal development that occurs in individuals of low birth weight increases the risk of renal diseases during adulthood [@B7]. The process of nephrogenesis in the rats starts during mid-gestation and finishes by post-natal day 14 [@B8]. Previous studies demonstrated that maternal low-protein diet in rats resulted in low birth weight, suppressed the renal renin-angiotensin system (RAS), and reduced the number of nephrons, leading to hypertension in offspring [@B9]. The aging process of the kidney is associated with physiological and functional changes, including reduced kidney weight and glomerular number, and changes in the shape of glomeruli and the formation of glomerular arterioles [@B10]. These changes in combination with decrease in renal function lead to hypertension and other cardiovascular diseases. The RAS is associated with one of the mechanisms that are involved in developmental problems in fetal organs, including the kidney [@B11]. Angiotensin II is the primary peptide in the system, which activates two subtypes of G-protein coupled receptors: angiotensin II type 1 (AT~1~R) and type 2 (AT~2~R) receptors. The AT~1~R plays a key role in the regulation of blood pressure, hormone secretion and renal function while AT~2~R is involved mainly in the development and growth [@B12].

Little is known about the effect of common fetal stress of hypoxia on the kidney development. Therefore, in the present study, we determined the effect of fetal hypoxia on the glomerular development and the expression patterns of AT~1~R and AT~2~R in the kidney in three developmental stages of near-term fetal, neonatal, and adult rats. The results suggest that fetal hypoxia causes programming of aberrant kidney development and accelerates the aging process of the kidney during the postnatal development, which may contribute to an increased risk of cardiovascular disease, particularly hypertension in offspring.

Material and Methods
====================

*Experimental Animals and Hypoxic Exposure.* Time-dated pregnant Sprague-Dawley rats were purchased from Charles River Laboratories (Portage, MI) and were randomly divided into normoxic control group and continuous hypoxic exposure group. The hypoxic group was exposed to 10.5% oxygen from day 15 to day 21 of gestation, a period comparable with the third trimester of gestation in humans. Hypoxia was induced to the pregnant rats by a mixture of nitrogen gas and air in individual chambers as described previously [@B13]. The normoxic control group was housed identically with room air flowing through chambers. Water and food were provided as desired. Some of the pregnant rats, of both groups, were allowed to give birth naturally, and no fetal loss in the normoxia or hypoxia groups was observed. The offspring were allowed to lactation and no further treatment before euthanasia at postnatal day 7 (P7) and 3 month-old (3M). The other pregnant dams were sacrificed on day 21 of gestation and fetuses (E21) were collected for studies. Kidneys were isolated and stored at -80°C. Body and kidney weight was determined. All procedures and protocols used in the present study were approved by the Institutional Animal Care and Use Committee of Loma Linda University and followed the guidelines in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

*Immunoblotting.* Protein abundance of renal AT~1~R and AT~2~R was determined with Western blot analysis as reported previously [@B14]. Briefly, kidneys were homogenized in an ice-cold lysis buffer (20 mM HEPES, 10 mM KCl, 1.5 mM MgCl~2~, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride and 2 μg/ml aprotinin, pH 7.4). Homogenates were centrifuged at 4°C for 10 min at 14,000 g, and supernatants aliquots were collected and stored at -80°C. Protein concentrations were determined using a protein assay kit from Bio-Rad. Samples with equal protein (40 μg) were loaded on 7.5% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) and performed the electrophoresis analysis. After electrophoresis, proteins were transferred to nitrocellulose membranes. Nonspecific binding was blocked in TBST containing 5% dry milk for 60 min at room temperature. The membranes were incubated with rabbit AT~1~R and AT~2~R polyclonal antibody (1:1000 and 1:2000 dilution respectively; Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4°C. The membranes were then washed and incubated with secondary horseradish peroxidase-conjugated goat anti-rabbit antibody (1:4000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA). Protein bands were visualized with enhanced chemiluminescence reagents, and the blots were exposed to Hyperfilm (GE Healthcare). Results were analyzed and quantified by the Kodak electrophoresis documentation and analysis system with Kodak ID image analysis software. For comparison of the levels of AT~1~R and AT~2~R protein relative density between the groups, samples were normalized first to GAPDH values and then presented as fold values relative to control animals.

*RT-PCR.*RNA was isolated from kidneys of adult offspring using TRIzol reagents (Invitrogen, Carlsbad, CA, USA) and was subjected to reverse transcription with Superscript III First-Strand Synthesis System (Invitrogen), following the manufacturer\'s instructions. Briefly, 5 µg total RNA was reverse transcribed into cDNA in a 20 µl volume reaction following the protocol of 50°C for 50 min and 85°C for 5 min. The mRNA abundance of AT~1a~R and AT~1b~R was measured with real-time PCR using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA, USA). GAPDH was used as internal reference. Primers used for AT~1a~R: 5′-ccattcaccctgcctcag-3′ (forward) and 5′-acggctttgcttggttactc-3′ (reverse) and for AT~1b~R: 5′-atgtctccagtcccctctca-3′ (forward) and 5′-tgacctcccatctccttttg-3′ (reverse). Real-time PCR was performed in a final volume of 25 µl and each PCR reaction mixture consisted of 500 nM of primers and iQ SYBR Green Supermix containing 0.625 unit hot-start Taq polymerase, 400 µM each of dATP, dCTP, dGTP, and dTTP, 100 mM KCl, 16.6 mM ammonium sulfate, 40 mM Tris-HCl, 6 mM MgSO~4~, SYBR Green I, 20 nM fluorescing and stabilizers. We used the following real time-PCR protocol: 95°C for 10 min, followed by 40 cycles of 95°C for 10 s, annealing for 10 s at appropriate temperature depending on the primer sequence, 72°C for 10 s. Serial dilutions of the positive control were done on each plate to create a standard curve for the quantification.

*Glomerular counting.*The number of glomeruli per kidney was determined for P7 and 3M female and male rats as previously described [@B15]. Briefly, kidneys were removed and weighed. Whole kidneys were incubated in 50% hydrochloric acid for 45 min at 37°C, the incubation time being dependent on kidney weight. Kidneys were rinsed with tap water and stored overnight at 4°C in a gauged flask. Following mechanical dissociation, tubules and glomeruli were suspended in 10 ml of distilled water. Three 0.5-ml aliquots were obtained from each kidney homogenate and placed in a hemocytometer-like chamber, and glomeruli were counted under microscope by two investigators who were unaware of the specimen origin. The three results were averaged, and then the value was used to determine the total number of glomeruli in the sample and therefore in the kidney.

*Statistical analysis.* Results are expressed as mean ± standard error of mean (SEM). Experimental number (N) represents fetuses and offspring from different dams. Statistical comparisons for the body and kidney weight, the kidney to body weight ratio, and the number of glomeruli were conducted by two-way ANOVA followed by a Bonferroni test. Differences in AT~1~R or AT~2~R protein abundance between normoxic and hypoxic groups were compared using unpaired t-test analysis. In all cases the differences were considered significant when *P* \< 0.05.

Results
=======

*Effects of fetal hypoxia on body and kidney weight.*Fetal hypoxia resulted in a significant decrease in body and kidney weight in E21 and P7 rats (Figure [1](#F1){ref-type="fig"}A, [1](#F1){ref-type="fig"}B). The kidney-to-body weight ratio was significantly higher in P7 rats than that in E21 rats (Figure [1](#F1){ref-type="fig"}C), indicating a continuous growth and maturation of the kidney in neonatal rats. Hypoxia treatment decreased the kidney-to-body weight ratio in E21 rats but increased it in P7 rats (Figure [1](#F1){ref-type="fig"}C). In 3M offspring, there were no significant differences in body and kidney weight in either males or females between the control and hypoxic-treated animals (Figures [1](#F1){ref-type="fig"}D and [1](#F1){ref-type="fig"}E). The kidney-to-body weight ratio was not significantly different between males and females in adult offspring, but both were significantly decreased as compared with that in P7 neonates (Figures [1](#F1){ref-type="fig"}C and [1](#F1){ref-type="fig"}F). Fetal hypoxia had no significant effect on the kidney-to-body weight ratio in either male or female adult offspring (Figure [1](#F1){ref-type="fig"}F).

*Effects of fetal hypoxia on renal AT~1~R and AT~2~R protein and mRNA abundance.*The protein abundance of AT~1~R and AT~2~R in the kidney was determined by Western blot analysis. As shown in figure [2](#F2){ref-type="fig"}, AT~1~R protein abundance in the kidney was not significantly different in either fetal or neonatal rats between the control and hypoxic-treated animals. However, in adult offspring, AT~1~R protein abundance in the kidney was significantly decreased in both males (43%) and females (62%) that had exposed to hypoxia before birth, as compared with the control animals (Figure [2](#F2){ref-type="fig"}). Consistent with the decreased AT~1~R protein abundance, fetal hypoxia resulted in a significant decrease in mRNA abundance of AT~1a~R and AT~1b~R in the kidney of both male and female offspring (Figure [3](#F3){ref-type="fig"}). In contrast, fetal hypoxia had no significant effect on AT~2~R protein abundance in the kidney at all three developmental stages examined (Figure [4](#F4){ref-type="fig"}). Thus, prenatal hypoxia significantly decreased the AT~1~R to AT~2~R ratio in the kidney of adult offspring (Figure [5](#F5){ref-type="fig"}).

*Effects of fetal hypoxia on glomerular number.*Figure [6](#F6){ref-type="fig"} shows the effect of fetal hypoxia on total number of glomeruli per kidney in neonates and adult offspring. In P7 neonates, there was a small but significant decrease in kidney glomerular numbers in hypoxic-treated animals, as compared with the normoxic pups (Figure [6](#F6){ref-type="fig"}). This hypoxia-mediated reduction of nephron numbers was progressively worsened into the adulthood with females (52% reduction) affected more than males (26% reduction) (Figure [6](#F6){ref-type="fig"}).

Discussion
==========

There is plenty of evidence that correlates low birth weight in term gestation with an increased risk of cardiovascular disease during adulthood [@B16]. The present finding that fetal hypoxia caused a significant decrease in the body weight of fetal and neonatal rats is consistent with the previous studies [@B17]. No significant difference was observed in the adult offspring between normoxia and hypoxia-treated animals in the present study, suggesting "catch-up" growth during postnatal development in hypoxia-treated animals. A number of studies have shown that *in utero* undernutrition causes fetal growth restriction and low birth weight, which is associated with "catch-up" growth during postnatal development [@B18], [@B19]. These studies suggest a common response of decreased body weight in early developmental stage and "catch-up" growth in postnatal development in fetal malnutrition and fetal hypoxia models. It has been shown that low birth weight associated with accelerated postnatal growth is a trigger for development of adult disease and ultimately can affect longevity [@B20].

In the present study, fetal hypoxia resulted in a decrease in the kidney weight in the fetus and neonate. However in adult offspring, the kidney weight was not significantly different between the control and hypoxic-treated animals in both females and males. Interesting, perinatal nicotine exposure affected the kidney weight not just in the fetus and neonate but also in female and male adult offspring [@B21]. The finding that the kidney-to-body weight ratio was significantly greater in P7 rats than that in E21 rats indicates a continuous growth and maturation of the kidney in neonatal rats. This is consistent with the previous finding that the process of nephrogenesis in the rats starts during mid-gestation and finishes by postnatal day 14 [@B8]. The finding that the kidney-to-body weight ratio was significantly decreased in adult rats as compared with that in neonatal rats is intriguing and suggests asymmetric growth and aging process of reduced kidney weight during the postnatal development [@B11]. Hypoxia decreased the kidney-to-body weight ratio in E21 rats. It has been demonstrated that fetal hypoxia results in a decrease of amniotic fluid production and redistribution of fetal blood flow with a decrease in perfusion to the kidney and an increase of perfusion to the brain, heart and liver [@B22]. The finding of the increased kidney-to-body weight ratio in P7 rats in hypoxic animals suggests a compensatory growth of the kidney in neonates. Similar to the present finding, maternal protein restriction caused a decrease in the kidney-to-body weight ratio in the newborn and P1 offspring, but in P5 there was no difference in the ratio between the low protein diet and control groups [@B19].

Abnormal development of the kidney may affect adult cardiovascular and renal function. Brenner *et al.* [@B23] introduced the hypothesis that due to a lower nephron number the surface area of filtration is smaller, leading to an increase in glomerular pressure and systematic hypertension. There is plenty of evidence regarding the existence of a relationship between lower nephron number and hypertension in humans [@B24] and in rats [@B25]. Several different animal models including maternal alcohol administration and high salt diet during pregnancy demonstrated the reduced nephron number and increased blood pressure in adult offspring [@B25]. Woods *et al.* reported that the maternal protein restriction decreased the number of nephrons in adult kidneys. Interesting, they found that although the degree of hypertension in male and female adult rats was similar, the number of nephrons in males was lower than that in females [@B19]. In contrast to the findings in animal models of low protein diet and high salt diet [@B19], fetal hypoxia resulted in a greater reduction in the nephron number in female (52%) than male (26%) adult offspring. These findings suggest differential effects of fetal insults on gender-specific programming of aberrant nephron development. Although it is generally perceived, at least in human, that the number of glomeruli does not change after birth in rats the nephrogenesis starts in mid-gestation and continues up to day 14 neonates. In the present study, hypoxia caused a decrease in glomerular number in P7 neonates and a rest of nephrogenesis, resulting in significantly reduced glomeruli in the adult kidney. Whereas the total glomerular volume was not determined in the present study, the effect of hypoxia on the functional maturation and glomerular volume may not be excluded given that the mean glomerular volume has been shown to be programed by fetal stress and has an impact on kidney disease and hypertension [@B25], [@B26]. The finding that the kidney-to-body weight ratio was not difference in adult rats even though the number of glomeruli is significantly lower for the hypoxia group, may be due to glomerular hypertrophy that help maintain renal filtration surface area. This, however, may in turn lead to adverse effects in the kidney as a result of chronic glomerular hyperfiltration [@B27]. The reduction of nephron numbers may accelerate the aging process of the kidney and contribute to an increased risk of cardiovascular disease, particularly hypertension in offspring. It has been shown that the aging process of the kidney is associated with reduced glomerular number, which contributes to an increased risk of hypertension and other cardiovascular diseases[@B11].

The Renin-Angiotensin System (RAS) is a key regulator of blood pressure, fluid/electrolyte homeostasis, and kidney development [@B3], [@B28]. A recent study demonstrated that prenatal nicotine exposure did not affect the expression of AT~1~R in rat kidneys of 14-days, 30-days and 3-month offspring, as compared with the control groups [@B21]. However, the nicotine treatment decreased the expression of AT~2~R in all the three post-natal ages. The present study demonstrated that fetal hypoxia decreased the mRNA and protein expression of AT~1~R in adult offspring but had no effect on AT~2~R expression, suggesting that different maternal stresses affect the organogenesis of the kidney in different manners. Additionally, it has been shown that maternal protein restriction diet suppresses the expression of renal RAS probably due to the reduced number of glomeruli per kidney, which is associated with the increased arterial blood pressure in the adult rats [@B3]. Using losartan, an antagonist for AT~1~R, Woods et al. demonstrated that AT~1~R played a key role in fetal programming of aberrant renal development and hypertension in offspring [@B9]. In the present study, we demonstrated that fetal hypoxia did not affect the expression of AT~1~R in E21 and P7 rats, but significantly decreased AT~1~R expression in adult offspring. Additionally, this effect is more pronounced in females than males. This is consistent with the finding of the greater reduction in nephron numbers in female than male adult offspring and suggests that the decreased AT~1~R in adult kidneys is due to reduced nephron numbers in hypoxic-treated animals. This finding raises the possibility of a sex-dependent effect due to maternal hypoxia on the renal AT~1~R expression may lead to sex differences on the impact of maternal hypoxia on adult disease. The finding that AT~2~R in the kidney was not significantly affected by fetal hypoxia in all the developmental ages examined in the present study suggests a predominate location of AT~2~R in extra-nephron tissues in the kidney. Indeed, Miyata *et al.* [@B29] demonstrated that AT~1~R, but not AT~2~R, mRNA was detected in the nephron. AT~1~R and AT~2~R have different function and imbalance of AT~1~R and AT~2~R expression and activity contributes to various kidney disorders [@B30]. Although the present finding of antenatal hypoxia-induced reduction of AT~1~R/AT~2~R expression ratio in the kidney of adult offspring is likely to have a significant effect on the renal function, the expression of AT~1~R and AT~2~R alone may not be a measure of total RAS-mediated function in the kidney. Future studies are needed to investigate the effect of hypoxia on other RAS components as well as the post receptor signaling, which are also involved in the kidney function.

Although AT~1~R plays an important role in normal kidney development [@B31], fetal hypoxia had no effect on AT~1~R in the kidney but decreased nephron numbers in P7 rats, suggesting other mechanisms may be involved in the hypoxia-mediated abnormal nephron development. Possible mechanisms include Wnt4 that is required by the metanephric mesenchyme for differentiation into nephron epithelia [@B32], or fibroblast growth factor-2 [@B33] and transforming growth factor β-2 [@B34] that are capable of inducing nephrons. Another possible mechanism is that hypoxia may affect the expression of retinoid receptors that mediate remodeling process in epithelial cells associated with nephron genesis [@B35]. Additionally, it has been shown that hypoxia increases the expression of glucocorticoid receptors in the primary human renal cortex epithelial cells [@B36], and that glucocorticoids play an important role in accelerating the maturation process of the kidney function [@B37], [@B38]. Furthermore, the previous study demonstrated that hypoxia up-regulated the expression of angiopoietin-2 in cultured mouse kidney mesangial cells, which may have a synergistic paracrine role in the growth of glomerular endothelial during the development of the kidney [@B39]. In humans, it has been shown that the aging process of the kidney induces changes in anatomic and function of the renal system, including reduction of glomerular filtration rate (GFR), segmental glomerular sclerosis, reduction in the number of glomeruli and a decrease in renal mass [@B40]. These changes may result in chronic kidney diseases (CKD) a risk factor that eventually induced cardiac complications. Our results suggest that fetal hypoxia induces aberrant nephrogenesis and accelerates the aging process of the kidney. Additionally, the results suggest that the mechanisms other than the renal RAS may be involved in fetal hypoxia-mediated programming of abnormal kidney development. Future studies are required to further elucidate these unknown pathways.
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